Is MTEM or PM a better dividend investment in 2026?

MTEM currently yields 2000000.06% with a 5% 5-year dividend growth rate. PM yields 3.49% with 2.8% growth. The better choice depends on your goal: MTEM offers higher current income.

What is the dividend yield difference between MTEM and PM?

MTEM has a forward dividend yield of 2000000.06% ($2.00/share annually). PM yields 3.49% ($5.76/share annually). The yield gap is 1999996.57 percentage points.

Home › Compare › MTEM vs PM

MTEM vs PM: Dividend Comparison 2026

MTEM yields 2000000.06% · PM yields 3.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MTEM wins by $4.8792278646347776e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MTEM

● Live price

2000000.06%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.8792278646347776e+39M

Annual income

$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00

Full MTEM calculator →

Philip Morris International

● Live price

3.49%

Share price

$164.83

Annual div

$5.76

5Y div CAGR

17.2%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.6K

Annual income

$2,502.61

Full PM calculator →

Portfolio growth — MTEM vs PM

📍 MTEM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MTEM	PM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MTEM + PM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MTEM pays

PM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTEM

Annual income on $10K today (after 15% tax)

$170,000,005.10/yr

After 10yr DRIP, annual income (after tax)

$4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$297.03/yr

After 10yr DRIP, annual income (after tax)

$2,127.22/yr

At 15% tax rate, MTEM beats the other by $4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTEM + PM for your $10,000?

MTEM: 50%PM: 50%

100% PM50/50100% MTEM

Portfolio after 10yr

$2.4396139323173888e+39M

Annual income

$2,439,374,001,430,694,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

MTEM

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-24.9

Piotroski

2/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$194.30

+17.9% upside vs current

Range: $180.00 — $205.00

Altman Z

4.0

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTEM buys

PM buys

No recent congressional trades found for MTEM or PM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMTEMPM

Forward yield	2000000.06% ✓	3.49%
Annual dividend / share	$2.00	$5.76 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	17.2% ✓
Portfolio after 10y	$4.8792278646347776e+39M	$49.6K ✓
Annual income after 10y	$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00 ✓	$2,502.61
Total dividends collected	$4.8791964691115763e+39M	$11.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Buy	Buy

Year-by-year: MTEM vs PM ($10,000, DRIP)

Year	MTEM Portfolio	MTEM Income/yr	PM Portfolio	PM Income/yr	Gap
1← crossover	$200,010,706	$200,000,006.00	$11,650	$409.56	+$200.00M → MTEM
2	$3,738,731,992,770	$3,738,517,981,314.42	$13,592	$497.49	+$3738731.98M → MTEM
3	$65,315,068,744,949,500	$65,311,068,301,717,240.00	$15,882	$605.21	+$65315068744.93M → MTEM
4	$1,066,400,958,023,135,400,000	$1,066,331,070,899,578,300,000.00	$18,589	$737.41	+$1066400958023135.38M → MTEM
5	$16,272,185,237,131,282,000,000,000	$16,271,044,188,106,197,000,000,000.00	$21,794	$899.94	+$16272185237131282432.00M → MTEM
6	$232,054,281,880,765,440,000,000,000,000	$232,036,870,642,561,700,000,000,000,000.00	$25,597	$1,100.16	+$2.3205428188076545e+23M → MTEM
7	$3,092,799,715,549,616,000,000,000,000,000,000	$3,092,551,417,468,003,600,000,000,000,000,000.00	$30,118	$1,347.30	+$3.0927997155496157e+27M → MTEM
8	$38,524,114,942,504,994,000,000,000,000,000,000,000	$38,520,805,646,809,356,000,000,000,000,000,000,000.00	$35,505	$1,652.97	+$3.8524114942504996e+31M → MTEM
9	$448,468,947,092,778,960,000,000,000,000,000,000,000,000	$448,427,726,289,790,500,000,000,000,000,000,000,000,000.00	$41,940	$2,031.88	+$4.4846894709277894e+35M → MTEM
10	$4,879,227,864,634,777,500,000,000,000,000,000,000,000,000,000	$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00	$49,643	$2,502.61	+$4.8792278646347776e+39M → MTEM

MTEM vs PM: Complete Analysis 2026

MTEM — Stock

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Full MTEM Calculator →

PM — Consumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →

📬

Get this MTEM vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTEM vs SCHD MTEM vs JEPI MTEM vs O MTEM vs KO MTEM vs MAIN MTEM vs MO MTEM vs BTI MTEM vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.